Jeanna Welborn

Title(s)Professor, Hematology and Oncology
SchoolSchool of Veterinary Medicine
AddressCancer Ctr So, #3016
CA 95817
Phone916-734-3772
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 02; 22(1):43-69. Shah NP, Bhatia R, Altman JK, Amaya M, Begna KH, Berman E, Chan O, Clements J, Collins RH, Curtin PT, DeAngelo DJ, Drazer M, Maness L, Metheny L, Mohan S, Moore JO, Oehler V, Pratz K, Pusic I, Rose MG, Shomali W, Smith BD, Styler M, Talpaz M, Tanaka TN, Tantravahi S, Thompson J, Tsai S, Vaughn J, Welborn J, Yang DT, Sundar H, Gregory K. PMID: 38394770.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    2. CML and the WHO: Why? J Clin Oncol. 2024 Mar 20; 42(9):984-986. Berman E, Shah NP, Deninger M, Altman JK, Amaya M, Begna K, Bhatia R, Chan O, Collins R, Curtin P, DeAngelo DJ, Drazer M, Maness L, Metheny L, Mohan S, Moore J, Oehler V, Pratz K, Pusic I, Rose M, Shomali W, Smith BD, Styler M, Sweet K, Talpaz M, Tanaka T, Tantravahi S, Tsai S, Vaughn J, Welborn J, Yang D, Mauro M, Cortes J, Radich J, Druker B. PMID: 38086008.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center. Leuk Res. 2022 08; 119:106885. Othman T, Moskoff BN, Ho G, Tenold ME, Azenkot T, Krackeler ML, Fisch SC, Potter LA, Kaesberg PR, Welborn JL, Wun T, Esteghamat NS, Hoeg RT, Rosenberg AS, Abedi M, Tuscano JM, Jonas BA. PMID: 35738024.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    4. Planning for post-pandemic cancer care delivery: Recovery or opportunity for redesign? CA Cancer J Clin. 2021 01; 71(1):34-46. Cinar P, Bold R, Bosslet BA, Bota DA, Burgess D, Chew HK, Cohen JG, Elquza E, Gold KA, Kamiya E, Karlan BY, McKay RR, Patel SP, Ternavan K, Welborn J, Yamamoto M, Rugo HS. PMID: 32997807; PMCID: PMC7537198.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    5. Germline mutations predisposing to melanoma. J Cutan Pathol. 2020 Jul; 47(7):606-616. Toussi A, Mans N, Welborn J, Kiuru M. PMID: 32249949; PMCID: PMC8232041.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    6. A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia. Am J Hematol. 2019 11; 94(11):E291-E294. Tomlinson BK, Tuscano JM, Abedi M, Welborn J, Arora M, O'Donnell RT, Wun T, Jonas BA. PMID: 31379016.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    7. Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia. Hum Pathol (N Y). 2016 Sep; 5:6-9. Su RJ, Jonas BA, Welborn J, Gregg JP, Chen M. PMID: 27458550; PMCID: PMC4957580.
      View in: PubMed   Mentions: 7  
    8. Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma. Br J Haematol. 2014 May; 165(3):375-81. Tuscano JM, Dutia M, Chee K, Brunson A, Reed-Pease C, Abedi M, Welborn J, O'Donnell RT. PMID: 24606326.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    9. Angioleiomyoma: a benign tumor with karyotypic aberrations. Cancer Genet Cytogenet. 2010 Jun; 199(2):147-8. Welborn J, Fenner S, Parks R. PMID: 20471520.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    10. Features of polycythemia vera in the 8p12 myeloproliferative syndrome. Cancer Genet Cytogenet. 2010 May; 199(1):53-5. Welborn J, Fenner S, Parks R. PMID: 20417870.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    11. Review: erythropoietin or darbepoetin for anemia in patients with cancer produces both benefits and harms with no increase in survival. ACP J Club. 2007 Jan-Feb; 146(1):6. Welborn J. PMID: 17203926.
      View in: PubMed   Mentions: 1     Fields:    
    12. Fibrous hamartoma of infancy: a case report with associated cytogenetic findings. Arch Pathol Lab Med. 2005 Apr; 129(4):520-2. Lakshminarayanan R, Konia T, Welborn J. PMID: 15794678.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    13. Review: oral and intravenous antibiotics do not differ for effectiveness in febrile neutropenic patients with cancer. ACP J Club. 2005 Mar-Apr; 142(2):32. Welborn J. PMID: 15739979.
      View in: PubMed   Mentions:    Fields:    
    14. High-grade neuroendocrine carcinomas display unique cytogenetic aberrations. Cancer Genet Cytogenet. 2004 Nov; 155(1):33-41. Welborn J, Jenks H, Taplett J, Walling P. PMID: 15527900.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004 Sep-Oct; 10(5):294-300. Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, Lam KS, Lau DH, Meyers FJ, O'donnell RT, Richman C, Scudder S, Tanaka M, Tuscano J, Welborn J, Wun T, Gandara DR, Lara PN. PMID: 15530258.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    16. Acquired Robertsonian translocations are not rare events in acute leukemia and lymphoma. Cancer Genet Cytogenet. 2004 May; 151(1):14-35. Welborn J. PMID: 15120908.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    17. Blastic mantle cell lymphoma developing concurrently in a patient with chronic myelogenous leukemia and a review of the literature. Am J Hematol. 2004 Apr; 75(4):231-8. Rodler E, Welborn J, Hatcher S, Unger K, Larkin E, Gumerlock PH, Wun T, Richman C. PMID: 15054816.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    18. Constitutional chromosome aberrations as pathogenetic events in hematologic malignancies. Cancer Genet Cytogenet. 2004 Mar; 149(2):137-53. Welborn J. PMID: 15036890.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    19. Inversion of chromosome 12 and lineage promiscuity in hematologic malignancies. Cancer Genet Cytogenet. 2004 Jan 15; 148(2):91-103. Welborn J, Jenks H, Taplett J, Walling P. PMID: 14734219.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    20. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001 Mar 15; 19(6):1728-33. Lara PN, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O'Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS. PMID: 11251003.
      View in: PubMed   Mentions: 245     Fields:    Translation:Humans
    21. Platelet-erythrocyte adhesion in sickle cell disease. J Investig Med. 1999 Mar; 47(3):121-7. Wun T, Paglieroni T, Field CL, Welborn J, Cheung A, Walker NJ, Tablin F. PMID: 10198567.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    22. Platelet activation in patients with sickle cell disease. Br J Haematol. 1998 Mar; 100(4):741-9. Wun T, Paglieroni T, Rangaswami A, Franklin PH, Welborn J, Cheung A, Tablin F. PMID: 9531343.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    23. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med. 1997 May; 129(5):507-16. Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A. PMID: 9142047.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    24. Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer. Anticancer Res. 1997 May-Jun; 17(3B):1735-44. Denardo SJ, Richman CM, Goldstein DS, Shen S, Salako Q, Kukis DL, Meares CF, Yuan A, Welborn JL, Denardo GL. PMID: 9179227.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    25. A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study. Blood. 1996 Oct 15; 88(8):2841-51. Weick JK, Kopecky KJ, Appelbaum FR, Head DR, Kingsbury LL, Balcerzak SP, Bickers JN, Hynes HE, Welborn JL, Simon SR, Grever M. PMID: 8874180.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCTClinical Trials
    26. Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis. Cancer Res. 1995 Oct 01; 55(19):4220-4. Beverloo HB, Le Coniat M, Wijsman J, Lillington DM, Bernard O, de Klein A, van Wering E, Welborn J, Young BD, Hagemeijer A, et al. PMID: 7671224.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    27. Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia. Blood. 1995 Sep 01; 86(5):1717-28. Head D, Kopecky KJ, Weick J, Files JC, Ryan D, Foucar K, Montiel M, Bickers J, Fishleder A, Miller M, et al. PMID: 7655004.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    28. Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial. Leukemia. 1995 Jul; 9(7):1126-9. Welborn JL, Kopecky KJ, Meyers FJ, Veith R, Shurafa M, Doroshow JH, Balcerzak SP, Appelbaum FR. PMID: 7630183.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    29. Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults. Am J Hematol. 1994 Apr; 45(4):341-4. Welborn JL. PMID: 7909983.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Trisomy 21 and cystic hygromas in early gestational age fetuses. Am J Perinatol. 1994 Jan; 11(1):19-20. Welborn JL, Timm NS. PMID: 8155202.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    31. Banding resolution of human chromosomes: a method of accuracy and simplicity. Am J Med Genet. 1993 Dec 01; 47(8):1180-3. Welborn JL, Welborn R. PMID: 8291552.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    32. Correlation of marrow iron patterns with disease status of chronic myelogenous leukemia. Leuk Lymphoma. 1993 Aug; 10(6):469-75. Welborn JL, Lewis JP. PMID: 8401182.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood. 1993 Jun 15; 81(12):3197-203. Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL, Cleary ML. PMID: 8389614.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    34. 5q--in essential thrombocythemia. Cancer Genet Cytogenet. 1993 Jun; 67(2):150. Welborn J. PMID: 8330275.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    35. Unique clinical features and prognostic significance of the translocation (6;11) in acute leukemia. Cancer Genet Cytogenet. 1993 Feb; 65(2):125-9. Welborn JL, Jenks HM, Hagemeijer A. PMID: 8453597.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    36. Impact of polydonor mixed lymphocyte culture media on quantity and quality of myeloid metaphases. Cancer Genet Cytogenet. 1992 Jul 01; 61(1):46-9. Taylor N, Welborn JL, Lewis JP. PMID: 1386284.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    37. Blood transfusion reactions. Which are life-threatening and which are not? Postgrad Med. 1991 Dec; 90(8):125-8, 131-2, 135 passim. Welborn JL, Hersch J. PMID: 1749728.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Vincristine for thrombocytopenic purpura. Lancet. 1991 Feb 09; 337(8737):377-8. Welborn JL, O'Donnell R, Hsieh T, Eatherton J, Aspry K. PMID: 1671287.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. A three-point approach to anemia. Postgrad Med. 1991 Feb 01; 89(2):179-83, 186. Welborn JL, Meyers FJ. PMID: 1990391.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Rapid improvement of thrombotic thrombocytopenic purpura with vincristine and plasmapheresis. Am J Hematol. 1990 Sep; 35(1):18-21. Welborn JL, Emrick P, Acevedo M. PMID: 2389766.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    41. Analysis of mosaic states in amniotic fluid using the in-situ colony technique. Clin Genet. 1990 Jul; 38(1):14-20. Welborn JL, Lewis JP. PMID: 2201467.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. Infusion carboplatin treatment of relapsed and refractory acute leukemia: evidence of efficacy with minimal extramedullary toxicity at intermediate doses. J Clin Oncol. 1989 Feb; 7(2):173-8. Meyers FJ, Welborn J, Lewis JP, Flynn N. PMID: 2644396.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    43. Impact of reinduction regimens on the clinical course of adult acute nonlymphocytic leukemia. Leukemia. 1988 Nov; 2(11):711-6. Welborn JL, Lewis JP, Meyers FJ. PMID: 3054348.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Improved approach to patients with normocytic anemia. Am Fam Physician. 1988 Aug; 38(2):191-5. Meyers FJ, Welborn JL, Lewis JP. PMID: 3407586.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    45. Renal salt wasting and carboplatinum. Ann Intern Med. 1988 Apr; 108(4):640. Welborn J, Meyers FJ, O'Grady LF. PMID: 3279897.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. Diagnostic and prognostic significance of t(1;3)(p36;q21) in the disorders of hematopoiesis. Cancer Genet Cytogenet. 1987 Oct; 28(2):277-85. Welborn JL, Lewis JP, Jenks H, Walling P. PMID: 3476187.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    47. Mast cell disease followed by leukemia with clonal evolution. Leuk Res. 1987; 11(9):769-73. Lewis JP, Welborn JL, Meyers FJ, Levy NB, Roschak T. PMID: 3118098.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    Jeanna's Networks
    Concepts (258)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (37)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California